Is it important to report the following anomaly to the judge OING or to lawyer Shapiro?
Few years ago, Pfizer said that Bapineuzumab does not work ... Nevertheless, Pfizer continues research in Europe by Wyeth Pharmaceuticals Inc. (Wholly owned subsidiary) ... Pfizer is behaving like Ponezumab, they say that does not work, however trials are ongoing ...
Trial status: ongoing for FRANCE, BELGIUM, SLOVAKIA
Trial protocol: FR (Ongoing) GB (Prematurely Ended) BE (Ongoing) ES (Prematurely Ended) PT (Prematurely Ended) SK (Ongoing) IT (Prematurely Ended) FI (Prematurely Ended) NL (Prematurely Ended) SE (Prematurely Ended) AT (Prematurely Ended) DE (Prematurely Ended)
National Competent Authority: FRANCE Name of Sponsor: Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola road, Collegeville, PA 19426 USA
National Competent Authority: BELGIUM Name of Sponsor: Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola road, Collegeville, PA 19426 USA
National Competent Authority: SLOVAKIA Name of Sponsor: Wyeth Pharmaceuticals Inc, a wholly owned subsidiary of Pfizer Inc, 500 Arcola road, Collegeville, PA 19426 USA
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.